Sara Wu
Executive Director of Pharmaceutical Development at Celcuity | Chapel Hill, North Carolina, United States
Sara Wu’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
Senior Director of Pharmaceutical Development at G1 Therapeutics, Inc. in July 2018 - Present
Executive Director of Pharmaceutical Development at Celcuity in November 2021 - Present
Senior Chemist, Director, Senior Director, Executive Director of Drug Product Development at Cempra Pharmaceuticals in December 2010 - July 2018
Senior Principal Scientist at Pfizer/Wyeth in June 2009 - September 2010
Research Scientist I and II at Eisai in January 2002 - May 2009
Senior Associate Scientist at Quintiles Corp in September 2000 - December 2001
Scientist III at Oread Inc in October 1998 - August 2000
Postdoctoral Research Fellow, Department of Pharmaceutical Chemistry at The University of Kansas in August 1997 - September 1998
The University of Kansas, Ph.D, January 1993 to January 1997
Celcuity is a clinical-stage, publicly traded biotechnology company seeking to extend the lives of cancer patients through the development of targeted therapies for the treatment of multiple solid tumor indications. The company was founded to develop a better way to treat the cellular drivers of tumor growth. Our lead therapeutic candidate, gedatolisib, is an intravenously administered, potential first-in-class PI3K/AKT/mTOR (PAM) pathway inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. Gedatolisib phase 3 clinical development programs are focused on the treatment of patients with HR+/HER2- ABC in the 1L and 2L settings. A Phase 1b/2 clinical trial evaluating gedatolisib in combination with darolutamide in patients with metastatic castration resistant prostate cancer, is on-going. Celcuity is headquartered in Minneapolis. Further information about Celcuity can be found at www.celcuity.com
Discover more about Celcuity
Lead, Field Strategic Account Management - Takeda Oncology
Lead, Field Strategic Account Management at Takeda Oncology
(September 2023 – Present)
Biopharma Pricing & Access Analytics
Head of Access Insights, Pricing and Analytics at Takeda
(November 2024 – Present)
Regional Medical Affairs Director at Mirati Therapeutics
Co-Chair, Career Development Committee for Postdocs at UT Southwestern Medical Center
(August 2026 – August 2026)
Director Clinical Operations at Celcuity
Director Clinical Operations at Celcuity
(August 2024 – Present)
Senior Principal Investigator | Cancer Research | Bioinformatics | Drug Discovery | AI/ML in Biotechnology
Senior Principal Investigator at Celcuity
(February 2024 – Present)
Vice President | Head of Medical Affairs
Independent Consultant at Self Employed
(January 2025 – Present)
What is Sara Wu email address?
Email Sara Wu at [email protected] and [email protected]. This email is the most updated Sara Wu's email found in 2026.
What is Sara Wu phone number?
Sara Wu phone number is +1.9199173803.
How to contact Sara Wu?
To contact Sara Wu send an email to [email protected] or [email protected]. If you want to call Sara Wu try calling on +1.9199173803.
What company does Sara Wu work for?
Sara Wu works for Celcuity.
What is Sara Wu's role at Celcuity?
Sara Wu is Executive Director of Pharmaceutical Development
